Members take our online CME/CE courses for FREE! View our NKF Professional Membership Benefits for more information on our other great benefits and to join online today!

To Dose or Not to Dose?: Poisonings and Medication Safety in CKD
The purpose of this activity is to enable the learner to be able distinguish safe and potentially toxic medications and substances to the CKD/ESRD population.
Target audience
  • Nurse Practitioner
  • Pharmacist
  • Physician
  • Physician Assistant
Content area(s)
  • Other topic
  • Pharmacology
  • Professional Development
Credits** 1.5
Controversies in Renal Replacement Therapy for Acute Kidney Injury
Participants will learn about the most current evidence around the prescription of renal replacement therapy for patients with acute kidney injury.
Target audience
  • Pharmacist
  • Physician
Content area(s)
  • Acute Kidney Injury
  • Other topic
Credits** 1.5
What’s New in Diabetic Kidney Disease
The purpose of this activity is to discuss the pathophysiology and natural history of diabetic kidney disease, the novel drugs used to treat hyperkalemia and evaluate their appropriate use, and the mechanism of action of novel drugs under study for treating diabetic kidney disease.
Target audience
  • Dietitian
  • Pharmacist
  • Physician
Content area(s)
  • Diabetes
Credits** 1.5
Cardiovascular Risk in Patients with Chronic Kidney Disease (CKD) The Impact of Anemia
This activity addresses the clinical challenge of treating anemia in CKD. Content focuses on CKD-related anemia and cardiovascular risk. The program also reviews benefits and limitations of current treatment options and explore emerging strategies for treating anemia in CKD.
Target audience
  • Dietitian
  • Nurse
  • Nurse Practitioner
  • Pharmacist
  • Physician
  • Physician Assistant
  • Social Worker
Content area(s)
  • Anemia
  • Cardiovascular Disease
  • Pharmacology
Credits** 1.5
Hepatitis C in Advanced Chronic Kidney Disease: Addressing the High-Risk Patient
Participants will immediately apply what is learned during this interactive case-based activity. The faculty focuses on cases to target patients who have HCV infection and CKD and promote patient centric measures. This is the second part of a two-part series.
Target audience
  • Dietitian
  • Nurse
  • Nurse Practitioner
  • Pharmacist
  • Physician
  • Physician Assistant
  • Social Worker
Content area(s)
  • Other topic
  • Patient Safety
  • Pharmacology
Credits** 1.5
Chronic Hyperkalemia Management and Outcomes in CKD
Hyperkalemia is a disease with multiple causes and is associated with serious adverse outcomes. This activity describes the main causes of hyperkalemia and associated risk with kidney disease. Appropriate management of acute and chronic hyperkalemia will also be addressed.
Target audience
  • Dietitian
  • Nurse
  • Nurse Practitioner
  • Pharmacist
  • Physician
  • Physician Assistant
  • Social Worker
  • Transplant Coordinator
Content area(s)
  • Other topic
  • Pharmacology
Credits** 1.5
Challenges and Strategies of Managing Iron Deficiency Anemia in CKD
Managing iron deficiency can reduce the severity of anemia in patients with ND-CKD. Considerations for treating iron deficiency include improving iron stores to maintain acceptable hemoglobin concentration.
Target audience
  • Dietitian
  • Nurse
  • Nurse Practitioner
  • Pharmacist
  • Physician
  • Physician Assistant
  • Social Worker
  • Transplant Coordinator
Content area(s)
  • Anemia
  • Other topic
  • Pharmacology
Credits** 1.5
Managing the Life-Long Impact of Fabry Disease
Fabry disease is a genetic disorder with a broad heterogeneous presentation. It is associated with numerous complications, including cardiovascular and kidney disease. This activity will discuss the diagnosis and management of Fabry disease in children and adult patients.
Target audience
  • Dietitian
  • Nurse
  • Nurse Practitioner
  • Pharmacist
  • Physician
  • Physician Assistant
  • Social Worker
  • Transplant Coordinator
Content area(s)
  • Cardiovascular Disease
  • Other topic
  • Pharmacology
Credits** 1.5
Optimizing Management of Secondary Hyperparathyroidism
Secondary hyperparathyroidism (SHPT) is one of the most common complications in patients with chronic kidney disease (CKD) and end stage renal disease (ESRD). This activity provides an overview and update of the pathophysiology and therapy of SHPT.
Target audience
  • Dietitian
  • Nurse
  • Nurse Practitioner
  • Pharmacist
  • Physician
  • Physician Assistant
  • Social Worker
  • Transplant Coordinator
Content area(s)
  • Other topic
  • Pharmacology
Credits** 1.5
Autosomal Dominant Polycystic Kidney Disease: Clinical Challenges, Emerging Treatment
Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent hereditary kidney disease and a leading cause of ESRD.
Target audience
  • Dietitian
  • Nurse
  • Nurse Practitioner
  • Pharmacist
  • Physician
  • Physician Assistant
  • Social Worker
  • Transplant Coordinator
Content area(s)
  • Other topic
  • Pharmacology
Credits** 1.5

Pages